Pig liver xenotransplantation as a bridge to allotransplantation: Which patients might benefit?

Transplantation

Volumn 88, Issue 9, 2009, Pages 1041-1049

  Ekser, Burcin ^a,b   Gridelli, Bruno ^c   Tector, A Joseph ^d   Cooper, David K C ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

^c MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

^d INDIANA UNIVERSITY   (United States)

Author keywords

Acute liver failure; Allotransplantation; Bioartificial liver; Liver; Patient selection; Pig; Xenotransplantation.

Indexed keywords

ALLOTRANSPLANTATION; BIOARTIFICIAL LIVER; BLOOD CLOTTING DISORDER; DETERIORATION; GENETIC ENGINEERING; GRAFT FAILURE; HEPATOCYTE TRANSPLANTATION; HUMAN; INFORMED CONSENT; LIVER FAILURE; LIVER FUNCTION; LIVER PERFUSION; PATIENT SELECTION; PREGNANCY; PRIORITY JOURNAL; REVIEW; SWINE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; XENOTRANSPLANTATION;

ANIMALS; HEPATECTOMY; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; PLASMAPHERESIS; PRIMATES; SWINE; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT FAILURE; TREATMENT OUTCOME; WAITING LISTS;

EID: 72949090557     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181ba0555     Document Type: Review

References (89)

1. OPTN-Organ Procurement and Transplantation Network. Available at: http://www.optn.org/latestData/rptData.asp. Accessed March 25, 2009.
2. UNOS-United Network for Organ Sharing. Available at: http://www. unos.org. Accessed March 25, 2009.
3. Cooper DKC, Gollackner B, Sachs DH. Will the pig solve the transplantation backlog? Annu Rev Med 2002; 53: 133.
4. Cooper DKC, Dorling A, Pierson RN III, et al. a1,3-galactosyltrans-ferase gene-knockout pigs for xenotransplantation: Where do we go from here? Transplantation 2007; 84: 1.
5. Kuwaki K, Tseng YL, Dor FJMF, et al. Heart transplantation in baboons using a1,3-galactosyltransferase gene-knockout pigs as donors: Initial experience. Nat Med 2005; 11: 29.
6. Tseng YL, Kuwaki K, Dor FJ, et al. a1,3-Galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching 6 months. Transplantation 2005; 80: 1493.
7. Cozzi E, Bhatti F, Schmoeckel M, et al. Long-term survival of non-human primates receiving life-supporting transgenic porcine kidney xenografts. Transplantation 2000; 70: 15.
8. Yamada K, Yazawa K, Shimizu A, et al. Marked prolongation of porcine renal xenograft survival in baboon through the use of alpha 1,3- galactosyltransferase gene-knockout donors and the cotrans-plantation of thymic tissue. Nat Med 2005; 11: 32.
9. Hara H, Gridelli B, Lin YJ, et al. Liver xenografts for the treatment of acute liver failure: Clinical and experimental experience and remaining immunologic barriers. Liver Transplant 2008; 14: 425.
10. Ekser B, Rigotti P, Gridelli B, et al. Xenotransplantation of solid organs in the pig-to-primate model. Transplant Immunol 2009; 21: 87.
11. Tector AJ, Fridell JA, Watanabe T, et al. Pulmonary injury in recipients of discordant hepatic and renal xenografts in the dog-to-pig model. Xenotransplantation 1998; 5: 44.
12. Gridelli B, Gatti S, Piazzini A, et al. Xenogeneic orthotopic liver transplantation from sheep to pig. Transplant Proc 1992; 24: 614.
13. Gridelli B, Gatti S, Andreani P, et al. Xenogeneic orthotopic liver transplantation from sheep to pig: Delay of rejection by FUT 175 infusion. Transplant Proc 1996; 28: 784.
14. Mieles L, Ye Y, Luo Y, et al. Auxillary liver allografting and xenografting in the nonhuman primate. Transplantation 1995; 59: 1670.
15. Luo Y, Kosanke S, Mieles L, et al. Comparative histology of hepatic allografts and xenografts in the nonhuman primate. Xenotransplantation 1998; 5: 197.
16. Gridelli B, Gatti S, Piazzini A, et al. Xenogeneic orthotopic liver transplantation in nonhuman primates. Transplant Proc 1993; 25: 457.
17. Zhong R, Tucker J, Zhang Z, et al. The long-term survival of baboon-to-monkey kidney and liver xenografts. Xenotransplantation 2003; 10: 398.
18. Calne RY, White HJO, Herbertson BM, et al. Pig to baboon liver xeno-grafts. Lancet 1968; 1: 1176.
19. Powelson J, Cosimi AB, Austen W, et al. Porcine to primate orthotopic liver Tx. Transplant Proc 1994; 26: 1353.
20. Ramirez P, Chavez R, Majado M, et al. Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days. Transplantation 2000; 70: 989.
21. Ramirez P, Montoya MJ, Rios A, et al. Prevention of hyperacute rejection in a model of orthotopic liver xenotransplantation from pig to baboon using polytransgenic pig livers (CD55, CD59, and H-transferase). Transplant Proc 2005; 37: 4103.
22. Makowka L, Cramer DV, Hoffman A, et al. The use of pig liver xeno-graft for temporary support of a patient with fulminant hepatic failure. Transplantation 1995; 59: 1654.
23. Rozga J. Liver support technology-an update. Xenotransplantation 2006; 13: 380.
24. van de Kerkhove MP, Hoekstra R, Chamuleau RA, et al. Clinical application of bioartificial liver support systems. Ann Surg 2004; 240: 216.
25. Horslen SP, Hammel JM, Fristoe LW, et al. Extracorporeal liver perfusion using human and pig livers for acute liver failure. Transplantation 2000; 70: 1472.
26. Fisher RA, Strom SC. Human hepatocyte transplantation: Worldwide results. Transplantation 2006; 82: 441.
27. Wu A, Buhler L, Cooper DKC. ABO-incompatible organ and bone marrow transplantation. Transpl Int 2003; 16: 291.
28. Farges O, Kalil A, Samuel D, et al. The use of ABO-incompatible grafts in liver transplantation: A life-saving procedure in highly selected patients. Transplantation 1995; 59: 1124.
29. Stussi G, West L, Cooper DKC, et al. ABO-incompatible allotransplan-tation as a basis for clinical xenotransplantation. Xenotransplantation 2006; 13: 390.
30. Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transplant 2003; 9: 651.
31. Chun LJ, Tong MJ, Busuttil RW, et al. Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol 2009; 43: 342.
32. Arroyo V, Fernandez J, Gines P. Pathogenesis and treatment of hepa-torenal syndrome. Semin Liver Dis 2008; 28: 81.
33. Munoz SJ. Hepatorenal syndrome. Med Clin North Am 2008; 92: 813.
34. McCormick PA, Donnelly C. Management of hepatorenal syndrome. Pharmacol Ther 2008; 119: 1.
35. Ruiz R, Barri YM, Jennings LW, et al. Hepatorenal syndrome: A proposal for kidney after liver transplantation. Liver Transplant 2007; 13: 838.
36. Kjaergard LL, Liu J, Als-Nielsen B, et al. Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: A systematic review. JAMA 2003; 289: 217.
37. Jalan R, Williams R. Acute-on-chronic liver failure: Pathophysiological basis of therapeutic options. Blood Purif 2002; 20: 252.
38. Abouna GM, Garry R, Hull C, et al. Pig-liver perfusionin hepatic coma. Lancet 1968; 2: 590.
39. Eiseman B, Liem DS, Raffucci F. Heterologous liver perfusion in treatment of hepatic failure. Ann Surg 1965; 162: 329.
40. Abouna GM. Extracorporeal xenogeneic liver perfusion for the treatment of liver failure. In: Cooper DKC, Kemp E, Platt JL, et al., eds. Xenotransplantation [ed. 2]. Germany, Springer 1997, p 785.
41. Chari RS, Collins BH, Magee JC, et al. Brief report: Treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation. N Eng J Med 1994; 331: 234.
42. Uemura T, Randall HB, Sanchez EQ, et al. Liver retransplantation for primary nonfunction: Analysis of a 20-year single-center experience. Liver Transpl 2007; 13: 227.
43. Ploeg RJ, D'Alessandro AM, Knechtle SJ, et al. Risk factors for primary dysfunction after liver transplantation-A multivariate analysis. Transplantation 1993; 55: 807.
44. Pokorny H, Gruenberger T, Soliman T, et al. Organ survival after primary dysfunction of liver grafts in clinical orthotopic liver transplantation. Transpl Int 2000; 13(suppl 1): S154.
45. Bekker J, Ploem S, de Jong KP. Early hepatic artery thrombosis after liver transplantation: A systematic review of the incidence, outcome and risk factors. Am J Transplant 2009; 9:1.
46. Lee WM. Etiologies of acute liver failure. Semin Liver Dis 2008; 28: 142.
47. Grabhorn E, Richter A, Fischer L, et al. Emergency liver transplantation in neonates with acute liver failure: Long-term follow up. Transplantation 2008; 86: 932.
48. Lee WM, Squires RH Jr, Nyberg SL, et al. Acute liver failure: Summary of a workshop. Hepatology 2008; 47: 1401.
49. Bernuau J, Rueff B, Benhamou J. Fulminant and subfulminant liver failure: Definition and causes. Semin Liver Dis 1986; 6: 97.
50. Bower WA, Johns M, Margolis HS, et al. Population-based surveillance for acute liver failure. Am J Gastroenterol 2007; 102: 2459.
51. Schiodt FV, Atillasoy E, Shakil AO, et al. Etiology and outcome for 295 patients with acute liver in the United States. Liver Transpl Surg 1999; 5: 29.
52. Shakil AO, KramerD, Mazariegos GV, et al. Acute liver failure: Clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000; 6: 163.
53. UK Transplant-United Kingdom Transplant. Available at: http://www. uktransplant.org.uk/. Accessed March 25, 2009.
54. Polson J, Lee W. AASLD position paper: The managementofacute liver failure. Hepatology 2005; 41: 1179.
55. Liou IW, Larson AM. Roleof liver transplantation in acute liver failure. Semin Liver Dis 2008; 28: 201.
56. O'Grady JG, Portmann B, Wiliamms R. Fulminant hepatic failure. In: Schiff L, Schiff R, eds. Diseases of the liver. Philadelphia, JB Lippincott 1993.
57. Bernal W, Wendon J, Rela M, et al. Use and outcome ofliver transplantation in acetaminophen induced acute liver failure. Hepatology 1998; 27: 1050.
58. Ostapowicz G, Fontana R, Schiodt F, et al. Results of a prospective study of acute liver failure at 17 tertiary care center in the United States. Ann Intern Med 2002; 137: 947.
59. Sgroi A, Serre-Beinier V, Morel P, et al. What clinical alternatives to whole liver transplantation? Current status of artificial devices and he-patocyte transplantation. Transplantation 2009; 87: 457.
60. van de Kerkhove MP, Di Lorio E, Scuderi V, et al. Phase I clinical trial with AMC-bioartificial liver. Int J Artif Organs 2002; 25: 950.
61. Ellis AJ, Hughes RD, Wendon JA, et al. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 1996; 24: 1446.
62. Demetriou AA, Brown RS, Busuttil RW, et al. Perspective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004; 239: 660.
63. Li AP, Roque MA, Beck DJ, et al. Isolation and culturing of hepatocytes from human livers. J Tiss Cult Meth 1992; 14: 136.
64. Levy MF, Crippin J, Sutton S, et al. Liver allotransplantation after ex-tracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers: Clinical results and lack of pig-to-human transmission of the porcine endogenous retrovirus. Transplantation 2000; 69: 272.
65. Strom SC, Bruzzone P, Cai H, et al. Hepatocyte transplantation: Clinical experience and potential for future use. Cell Transplant 2006; 15(suppl 1): s105.
66. Bilir BM, Guinette D, Karrer F, et al. Hepatocyte transplantation in acute liver failure. Liver Transplant 2000; 6: 32.
67. Di Carlo A, Tector AJ, Liu S, et al. Activation of porcine hepatic microvascular sinusoidal endothelial cells in pig-to-human liver xenotransplantation. Transplant Proc 2001; 33: 759.
68. Phelps CJ, Koike C, Vaught TD, et al. Production of 1,3- galactosyltransferase-deficient pigs. Science 2003; 299: 411.
69. Kolber-Simonds D, Lai L, Watt SR, et al. a1,3-galactosyltransferase null pigs via nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci USA 2004; 19: 7335.
70. Cozzi E, Tucker AW, Langford GA, et al. Characterization of pigs transgenic for human decay-accelerating factor. Transplantation 1997; 64: 1383.
71. Cooper DKC, Ezzelarab M, Hara H, et al. Recent advances in pig-to-human organ and cell transplantation. Expert Opin Biol Ther 2008; 8:1.
72. Sprangers B, Waer M, Billiau AD. Xenotransplantation: Where are we in 2008? Kidney Int 2008; 74: 14.
73. Tector AJ, Berho M, Fridell JA, et al. Rejection of pig liver xenografts in patients with liver failure: Implications for xenotransplantation. Liver Transpl2001; 7: 82.
74. Tector AJ, Fridell JA, Ruiz P, et al. Experimental discordant hepatic xenotransplantation in the recipient with liver failure: Implications for clinical bridging trials. J Am Coll Surg 2000; 191: 54.
75. Cooper DKC, Tseng Y-L, Saidman SL. Allo-and xenoantibody cross-reactivity in transplantation. Transplantation 2004; 77: 1.
76. Ibrahim Z, Busch J, Awwad M, et al. Selected physiologic compatibilities and incompatibilities between human and porcine organ systems. Xenotransplantation 2006; 13: 488.
77. Ekser B, Long C, Ezzelarab M, et al. Genetically-engineered pig liver transplantations in baboons: Initial results. Am J Transplant 2009; Suppl 2: 380.
78. Onions D, Cooper DKC, Alexander TJL, et al. An assessment of the risk of xenozoonotic disease in pig-to-human xenotransplantation. Xenotransplantation 2000; 7: 143.
79. Fishman JA, Patience C. Xenotransplantation: Infectious risk revisited. Am J Transplant 2004; 4: 1383.
80. Patience C, Stoye J. Infectious risk of clinical xenotransplantation. Curr Opin Organ Transplant 2004; 9: 176.
81. Louz D, Bergmans HE, Loos BP, et al. Reappraisal of biosaefty risks posed by PERVs in xenotransplantation. Rev Med Virol 2008; 18: 53.
82. Paradis K, Langford G, Long Z, et al. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissues. Science 1999; 285: 1236.
83. Wood JC, Quinn G, Suilling KM, et al. Identification of exogenous forms of human-tropic porcine endogenous retrovirus in miniature swine. J Virol 2004; 78: 2494.
84. Oldmixon BA, Wood JC, Ericsson TA, et al. Porcine endogenous retrovirus transmission characteristics of an inbred herd of miniature swine. J Virol 2002; 76: 3045.
85. Denner J. Recombinant porcine endogenous retroviruses (PERV-A/C): A new risk for xenotransplantation? Arch Virol 2008; 153: 1421.
86. Zhou NN, Senne DA, Landgraf JS, et al. Genetic reassortment of avian, swine, and human influenza A viruses in American pigs. J Virol 1999; 73: 8851.
87. Mueller NJ, Barth RN, Yamamoto S, et al. Activation of cytomegalovirus in pig-to-primate organ xenotransplantation. J Virol 2002; 76:4737.
88. Sykes M, d'Apice A, Sandrin M; IXA ethics committee. Position paper of the ethics committee of the International Xenotransplantation Association. Transplantation 2004; 78: 1101.
89. de Rave S, Tilanus HW, van der LJ, et al. The importance of orthotopic liver transplantation in acute liver failure. Transpl Int 2002; 15: 29.